Replacement of microglia by proliferation of resident microglia, infiltration of microglia-like cells and HSCT (described above) have been evaluated as therapeutic approaches for CSF1R-related leukoencephalopathy in mouse models and shown preliminary evidence of efficacy (91). This evidence concerns the gene CSF1R and Leukoencephalopathy.